Patent details

EP3529360 Title: METHODS FOR PREVENTING CARDIOVASCULAR EVENTS THROUGH PROPROTEIN CONVERTASE SUBTILISIN KEXIN 9 (PCSK9) PROTEIN REDUCTION

The time of generation of the report may vary depending on the number of the selected files and the pages of each file. If the generation of the consolidated PDF file takes long, you may reduce the number of selected files and proceed with the generation of the PDF in batches.
You have not selected any documents

Basic Information

Publication number:
EP3529360
WO Application Number:
US2017057218
Type:
European Patent Granted for NL
Status:
Patent in Force
Publication Title:
Title When Made Available For Viewing:
Reason Lapsed:
Application number:
EP17800976.7
WO Publication Number:
WO2018075658
EPO Publication Language:
English
SPC Number:
First Applicant Residence Country:
Switzerland (CH)
Publications:

Dates

Filing date:
18/10/2017
Grant date:
17/04/2024
EP Publication Date:
28/08/2019
WO Publication Date:
26/04/2018
Claims Translations Received Date:
Claims Translation B1 Received Date:
12/07/2024
Claims Translation B2 Received Date:
Claims Translation B3 Received Date:
Lapsed By Non Payment Annual Fee Date:
Renunciation Date:
NullificationDate:
Published:
Due To Cession Date:
Registration date:
17/04/2024
EP B1 Publication Date:
17/04/2024
EP B2 Publication Date:
EP B3 Publication Date:
Description Translation B1 Received Date:
Description Translation B2 Received Date:
Description Translation B3 Received Date:
Expiration date:
17/10/2037
Lapsed By Expiration Date:
Patent Validated Date:
08/08/2024
Revocation Date:
Invalidity Date:
Response To Novelty Search Report Received:
Patent Granting Request:
Lapsed date:

Applicant/holder

From:
17/04/2024
 
 

 

Name:
Novartis AG
Address:
Lichtstrasse 35, 4056, BASEL, Switzerland (CH)

Agent

Name:
dr. R.C. van Duijvenbode c.s.
From:
07/08/2024
Address:
NLO Postbus 29720, 2502 LS, Den Haag, Netherlands (NL)
To:

Inventor

1

Name:
WIJNGAARD, Peter
Address:
Parsippany NJ 07054, United States of America (US)

2

Name:
KALLEND, David
Address:
Parsippany NJ 07054, United States of America (US)

Priority

1

Priority Patent Number:
201762550426 P
Priority Date:
25/08/2017
Priority Country:
United States of America (US)

2

Priority Patent Number:
201762472525 P
Priority Date:
16/03/2017
Priority Country:
United States of America (US)

3

Priority Patent Number:
201662422028 P
Priority Date:
14/11/2016
Priority Country:
United States of America (US)

4

Priority Patent Number:
201662409816 P
Priority Date:
18/10/2016
Priority Country:
United States of America (US)

Classification

IPC or IDT classification:
C12N 15/113; A61K 31/713;

Publication

Bulletin

1

Bulletin Heading:
VB1
Journal edition number:
08/25
Publication date:
19/02/2025
Description:
Requests for restoration and notices of objection, notices of objection to Court, notices of objection to appelate court ex NL Patent Law 1995. Opposition(s) filed ex European Patent Convention

2

Bulletin Heading:
EP3
Journal edition number:
33/24
Publication date:
14/08/2024
Description:
European patents granted for the Netherlands in which a translation was filed ex Article 52 par. 1 of the NL Patent Law 1995

3

Bulletin Heading:
EP2
Journal edition number:
16/24
Publication date:
17/04/2024
Description:
European patents granted for the Netherlands

European Patent Bulletin

1

Issue number:
202508
Publication date:
19/02/2025
Description:
Opposition procedure started

2

Issue number:
202421
Publication date:
22/05/2024
Description:
Application number/publication number of the divisional application (Art. 76) changed

3

Issue number:
202416
Publication date:
17/04/2024
Description:
Grant (B1)

Annual Fee

Annual Fee(s) Due Date:
31/10/2025
Annual Fee Number:
9
Annual Fee Amount:
340 Euro
Last Annual Payment Date:
26/09/2024
Last Annual Fee Paid Number:
8
Last Annual Fee Paid Amount:
280 Euro
Payer:
Computer Patent Annuities Limited (CPA)
Filing date Document type Document Description Number of pages File Type
07/08/2024 Outgoing Correspondence Letter no formal defects 1 PDF /7/9/5/0/9/0800990597/docs/ep17800976.7_1_616422l271.pdf
12/07/2024 Claims First filed claims 3 PDF /7/9/5/0/9/0800990597/docs/ep17800976.7_0_claims20240712084514191.pdf